Boston Scientific to sell investments, pay down debt

CHICAGO, June 19 (Reuters) - Boston Scientific Corp (BSX.N) said on Thursday it would sell investments in a portfolio of companies and venture funds, raising total pre-tax proceeds of more than $140 million and resulting in a pre-tax loss of about $70 million.

The medical device maker, still heavily in debt after acquiring Guidant Corp, said it will use the money to pay down debt.